Second-line therapy in pancreatic cancer.


At the time of diagnosis most of patients present with advanced or metastatic pancreatic cancer, thereby precluding surgical resection. While the standard of care in the first line setting is established, there are limited data to support a standard second-line chemotherapy regimen. The authors summarize two interesting studies (Abstract #263 and Abstract… (More)
DOI: 10.6092/1590-8577/1463


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics